<?xml version="1.0" encoding="UTF-8"?>
<p id="par0165">In Catalonia, a consortium composed of the IRTA, the IrsiCaixa and the Barcelona Supercomputing Centre and a team from the Grifols pharmaceutical company, headed by Bonaventura Clotet and Oriol Mitj√† in the Infectious Diseases Department of Germans Trias Hospital, aim to develop a universal vaccine against all types of coronavirus, based on subunit 1 of protein S of the coronavirus envelope, which they consider to be the most useful target region for vaccine design.</p>
